Showing results (51-60 of 123) with videos related to

Sort By:
Pageof 13
Scandinavian Journal of Gastroenterology|July 9, 2008
Reconstitution of stratified murine and human oesophageal epithelia in an in vivo transplant culture systemDaniel Croagh, Shuli Cheng, Anjali Tikoo, et al.
BMC Biochemistry|December 29, 2012
Autophosphorylation of serine 608 in the p85 regulatory subunit of wild type or cancer-associated mutants of phosphoinositide 3-kinase does not affect its lipid kinase activityMeredith J Layton, Mirette Saad, Nicole L Church, et al.
Bioscience Reports|December 6, 2016
Assessing the subcellular distribution of oncogenic phosphoinositide 3-kinase using microinjection into live cellsMeredith J Layton, Natalie K Rynkiewicz, Ivan Ivetac, et al.
Cancer Research|September 11, 2013
Mutationally activated PIK3CA(H1047R) cooperates with BRAF(V600E) to promote lung cancer progressionChristy L Trejo, Shon Green, Victoria Marsh, et al.
Stem Cell Reports|July 9, 2026
The role of gastric cancer patient-derived organoids in precision medicine: Clinicians' perspectiveTharindie N Silva, Harleen Kaur, Tharani Krishnan, et al.
Annals of the New York Academy of Sciences|October 1, 2014
Molecular epidemiology of and genetic susceptibility to esophageal cancerManisha Bajpai, Kiron M Das, Joel Lefferts, et al.
Developmental Biology|May 11, 2015
Heterozygous expression of the oncogenic Pik3ca(H1047R) mutation during murine development results in fatal embryonic and extraembryonic defectsLauren M Hare, Quenten Schwarz, Sophie Wiszniak, et al.
Surgical Oncology|May 30, 2025
Neoadjuvant intraperitoneal chemotherapy in high-risk and cytology positive gastric cancer: a systematic reviewBrendan Desmond, Lobna Alukaidey, Zexi Allan, et al.
Science Advances|September 14, 2022
Eprenetapopt triggers ferroptosis, inhibits NFS1 cysteine desulfurase, and synergizes with serine and glycine dietary restrictionKenji M Fujihara, Bonnie Z Zhang, Thomas D Jackson, et al.
Oncotarget|December 22, 2017
PIK3CAH1047R-induced paradoxical ERK activation results in resistance to BRAFV600E specific inhibitors in BRAFV600E PIK3CAH1047R double mutant thyroid tumorsMatthias A Roelli, Dorothée Ruffieux-Daidié, Amandine Stooss, et al.
Pageof 13